Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nina I. Zolotarjova
Observed names:
Nina I Zolotarjova,
Nina Zolotarjova
Institution:
Incyte (United States)
Observed institutions:
University of Toledo Medical Center,
DuPont (United States),
Agilent Technologies (United States),
University of Georgia,
Bristol-Myers Squibb (United States),
Incyte (United States)
show all 6
OpenAlex ID:
A5048856410
Differences among techniques for high‐abundant protein depletion
2005
·
Nina Zolotarjova
, James Martosella
, et al.
·
PROTEOMICS
·
282
Reversed-Phase High-Performance Liquid Chromatographic Prefractionation of Immunodepleted Human Serum Proteins to Enhance Mass Spectrometry Identification of Lower-Abundant Proteins
2005
·
James Martosella
, Nina Zolotarjova
, et al.
·
Journal of Proteome Research
·
131
Absence of Post-translational Aspartyl β-Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia
2002
·
Joseph E. Dinchuk
, Richard J. Focht
, et al.
·
Journal of Biological Chemistry
·
108
Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry
2004
·
Giuseppina Maccarrone
, Dale Milfay
, et al.
·
Electrophoresis
·
94
Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum
2007
·
Nina Zolotarjova
, Peter Mrozinski
, et al.
·
Journal of Chromatography A
·
81
Different sensitivities of the Na+/K+-ATPase isoforms to oxidants
1994
·
Wu-hsiung Huang
, Yahong Wang
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
66
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated
2002
·
Jeffrey T. Billheimer
, Ira B. Dicker
, et al.
·
Blood
·
60
PDF
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies
2018
·
Matthew C. Stubbs
, Timothy C. Burn
, et al.
·
Clinical Cancer Research
·
51
High Recovery HPLC Separation of Lipid Rafts for Membrane Proteome Analysis
2006
·
James Martosella
, Nina Zolotarjova
, et al.
·
Journal of Proteome Research
·
49
Different sensitivities of native and oxidized forms of Na−K+-ATPase to intracellular proteinases
1994
·
Nina Zolotarjova
, Calvin Ho
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
49
Similarities and Differences between the Properties of Native and Recombinant Na+/K+-ATPases
1996
·
ZiJian Xie
, Yahong Wang
, et al.
·
Archives of Biochemistry and Biophysics
·
30
Interactions of Phosphorylation and Dimerizing Domains of the α-Subunits of Na+/K+-ATPase
1995
·
Mehdi Ganjeizadeh
, Nina Zolotarjova
, et al.
·
Journal of Biological Chemistry
·
28
Unusually Stable and Long-lived Ligand-induced Conformations of Integrins
2001
·
Nina I. Zolotarjova
, Gregory F. Hollis
, et al.
·
Journal of Biological Chemistry
·
20
PDF
Preclinical Evaluation of INCB160058 - a Novel and Potentially Disease-Modifying Therapy for JAK2V617F Mutant Myeloproliferative Neoplasms
2023
·
Matthew C. Stubbs
, Hamza Celik
, et al.
·
Blood
·
17
Abstract 3523: Discovery of a novel BET inhibitor INCB054329
2015
·
Phillip CC Liu
, Xuesong Mike Liu
, et al.
·
Cancer Research
·
14
Multi-Component Immunoaffinity Subtraction and Reversed-Phase Chromatography of Human Serum
2008
·
James Martosella
, Nina Zolotarjova
·
Methods in molecular biology
·
12
Abstract 5071: Preclinical characterization of the potent and selective BET inhibitor INCB057643 in models of hematologic malignancies
2017
·
Matthew C. Stubbs
, Thomas Maduskuie
, et al.
·
Cancer Research
·
11
Functional Coupling of Phosphorylation and Nucleotide Binding Sites in the Proteolytic Fragments of Na+/K+-ATPase
1995
·
Nina Zolotarjova
, Sankaridrug M. Periyasamy
, et al.
·
Journal of Biological Chemistry
·
10
PDF
ALK2 and JAK2 Inhibition for Improved Treatment of Anemia in Myelofibrosis Patients: Preclinical Profile of an ALK2 Inhibitor Zilurgisertib in Combination with Ruxolitinib
2023
·
Matthew C. Stubbs
, Michelle Pusey
, et al.
·
Blood
·
7
Sodium Pump Isoforms in Xenotransplantation: Importance of Biochemical Compatibility
2000
·
Andrea M Rose
, Hassan M Qazzaz
, et al.
·
Clinical Chemistry
·
7
Comparison of the Enzymatic and Cellular Profiles of Clinical JAK2 Inhibitors for the Treatment of Myelofibrosis
2023
·
Hamza Celik
, Maryanne Covington
, et al.
·
Blood
·
5
PDF
Comparison of the enzymatic and cellular profiles of clinical JAK inhibitors for the treatment of myelofibrosis
2026
·
Hamza Celik
, Brittney Wass
, et al.
·
Blood Neoplasia
·
4
Large-scale purification of active platelet integrin glycoprotein IIb–IIIa
2002
·
Milton C Hillman
, Nina I Zolotarjova
, et al.
·
Protein Expression and Purification
·
4
Abstract 6274: Preclinical characterization of the BET inhibitor, INCB057643, in combination with ruxolitinib for treatment of myeloproliferative neoplasms (MPN)
2023
·
Michelle Pusey
, Gaurang Trivedi
, et al.
·
Cancer Research
·
2
Abstract 4483: Novel small-molecule antagonists of the PD-1/PD-L1 axis that mediate cell surface PD-L1 dimerization and internalization
2019
·
Phillip C.C. Liu
, Richard Wynn
, et al.
·
Cancer Research
·
2
Show more works
View as search
Works count:
43
Citation count:
1,151
H-index:
14
I10-index:
18
Year
Topic
Type
